Clinical trial
Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
NCT00794625 is registered in ClinicalTrials.gov with Joseph Blader as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD
- Lead sponsor
- Joseph Blader
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 30, 2008
- Completion date
- April 30, 2013
- Enrollment
- 270 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.